Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia

Clinics

Volumn 65, Issue 6, 2010, Pages 575-581

  da Silva, Cléber Sergio ^a   Michelin, Marcia Antoniazi ^a   Etchebehere, Renata Margarida ^a   Adad, Sheila Jorge ^a   Candido Murta, Eddie Fernando ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

Cervical cancer; CIN III; Lymphocyte; Macrophages; Nitric oxide

Indexed keywords

LEUKOCYTE ANTIGEN; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CASE CONTROL STUDY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE COUNT; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADULT; AGED; AMBULATORY CARE FACILITIES; ANTIGENS, CD; B-LYMPHOCYTES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; HUMANS; LYMPHOCYTE COUNT; MIDDLE AGED; NITRIC OXIDE SYNTHASE; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77954917630     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000600003     Document Type: Article

References (32)

1. Caberg JH, Hubert PM, Begon DY, Herfs MF, Roncarati PJ, Boniver JJ, et al. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis. 2008;29:1441-7.
2. Herfs M, Herman L, Hubert P, Minner F, Arafa M, Roncarati P, et al. High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunol Immunother. 2009;58: 603-14.
3. Stanley MA. Human papillomavirus vaccines. Rev Med Virol. 2006;16:139-49.
4. Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004;64:6766-74.
5. Sahebali S, Van den Eynden G, Murta EF, Michelin MA, Cusumano P, Petignat P, et al. Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development. Eur J Cancer Prev. 2010;19:204-15.
6. Bell MC, Edwards RP, Partridge EE, Kuykendall K, Conner W, Gore H, et al. CD8+ T lymphocytes are recruited to neoplastic cervix. J Clin Immunol. 1995;15:130-36.
7. White HD, Yeaman GR, Givan AL, Wira CR. Mucosal immunity in the human female reproductive tract: cytotoxic T lymphocyte function in the cervix and vagina of premenopausal and postmenopausal women. Am J Reprod Immunol. 1997;37:30-8.
8. Witkin SS, Giraldo P, Linhares I, Ledger WJ. Individual immunity and susceptibility to female genital tract infection. Am J Obst Gynecol. 2000;183:252-6.
9. Gonçalves MA, Donadi EA. Immune cellular response to HPV: current concepts. Braz J Infect Dis. 2004; 8:1-9.
10. Heller DS, Hameed M, Cracchiolo B, Wiederkehr M, Scott D, Skurnick J, et al. Presence and quantification of macrophages in squamous cell carcinoma of the cervix. Int J Gynecol Cancer. 2003;13:67-70.
11. Brennan PA, Downie IP, Langdon JD, Zaki GA. Emerging role of nitric oxide in cancer. Br J Oral Maxillofacial Surg. 1999;37:370-3.
12. Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 1995;113:541-9.
13. Klotz T, Bloch W, Jacobs G, Niggemann S, Engelmann U, Addicks K. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology. 1999;54:416-9.
14. Lejeune P, Lagade CP, Onier N, Pinard D, Oshima H, Jeannin JF. Nitric oxide involvement in tumor-induced immuno-supression. J Immunol. 1994;152:5077-83.
15. Georgiannos SN, Renault A, Goode AW, Sheaff M. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery. 2003;134:827-34.
16. Pinzon-Charry A, Ho CS, Laherty R, Maxwell T, Walker D, Gardiner RA, et al. Population of HLA-DR+ Immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer. Neoplasia. 2005;7:1112-22.
17. Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Sem Cancer Biol. 2006;16: 38-52.
18. Maluf PJ, Michelin MA, Etchebehere RM, Adad SJ, Murta EF. T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III. Arch Gynecol Obstet. 2008;278:525-30.
19. Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ, et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol. 2005;58:1096-100.
20. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001; 357:539-45.
21. Loddenkemper C, Hoffmann C, Stanke J, Nagorsen D, Baron U, Olek S, et al. Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer. Cancer Sci. 2009;100:1112-7.
22. Blesson S, Their YJ, Gaudin C, Stancou R, Kolb JP, Moreau JL, et al. Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO. Int Immunol. 2002;14:1169-78.
23. Medot-Pirenne M, Heilman MJ, Saxena M, Mcdermott PE, Mills CD. Augmentation of an antitumor CTL response in vivo by inhibition of suppressor macrophage nitric oxide. J Immunol. 1999;163:5877-82.
24. Chen HHW, Su WC, Chou CY, Guo HR, Ho SY, Que J, et al. Increased expression of nitric oxide synthase and cyclooxygenase-2 is associated with poor survival in cervical cancer treated with radiotherapy. Int J Rad Onc Biol Phys. 2005;63:1093-100.
25. Mazibrada J, Rittà M, Mundini M, Andrea M, Azzimonti B, Borgogna C, et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol. 2008;108:112-20.
26. Hiraku Y, Tabata T, Ma N, Murata M, Ding X, Kawanishi S. Nitrative and oxidative DNA damage in cervical intraepithelial neoplasia associated with human papilloma virus infection. Cancer Sci. 2007;98:964-72.
27. Fernandes PC Jr, Garcia CB, Micheli DC, Cunha FQ, Murta EF, Tavares-Murta BM. Circulating neutrophils may play a role in the host response in cervical cancer. Int J Gynecol Cancer. 2007;17:1068-74.
28. Murta BMT, Resende AD, Cunha FQ, Murta EFC. Local profile of cytokines and nitric oxide in patients with bacterial vaginosis and cervical intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol. 2008;138:93-9.
29. Woo YL, Sterling J, Damay I, Coleman N, Crawford R, van der Burg SH, et al. Characterising the local immune responses in cervical intraepithelial neoplasia: a cross-sectional and longitudinal analysis. BJOG. 2008;115:1616-22.
30. Bell MC, Schmidt-Grimminger D, Turbat-Herrera E, Tucker A, Harkins L, Prentice N, et al. HIV1 Patients Have Increased Lymphocyte Infiltrates in CIN Lesions. Gynecol Oncol. 2000;76:315-9.
31. Gonçalves MAG, Soares EG, Donadi EA. The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infect Agent Cancer. 2009;4:11.
32. Petter A, Heim K, Guger M, Ciresa-Ko Nig A, Christensen N, Sarcletti M, et al. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women. J Gen Virol. 2000;81:701-8.